Drug Shortage Report for TOBI PODHALER

Last updated on 2024-11-04 History
Report ID 236492
Drug Identification Number 02365154
Brand name TOBI PODHALER
Common or Proper name TOBRAMYCIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 28MG
Dosage form(s) CAPSULE
Route of administration INHALATION INHALATION
Packaging size 4(7x8)
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-11-01
Actual start date 2024-10-25
Estimated end date 2025-02-11
Actual end date
Shortage status Actual shortage
Updated date 2024-11-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-11-04 French Compare
v16 2024-11-04 English Compare
v15 2024-11-02 English Compare
v14 2024-10-22 French Compare
v13 2024-10-22 English Compare
v12 2024-10-16 French Compare
v11 2024-10-16 English Compare
v10 2024-10-08 French Compare
v9 2024-10-08 English Compare
v8 2024-10-04 French Compare
v7 2024-10-04 English Compare
v6 2024-09-24 French Compare
v5 2024-09-24 English Compare
v4 2024-09-17 French Compare
v3 2024-09-17 English Compare
v2 2024-09-03 French Compare
v1 2024-09-03 English Compare

Showing 1 to 17 of 17